Circulating oxysterol metabolites as potential new surrogate markers in patients with hormone receptor-positive breast cancer: Results of the OXYTAM study
Florence DalencInserm UMR 1037, Team “Cholesterol metabolism and therapeutic innovations”, Cancer Research Center of Toulouse, Toulouse, FranceLuigi IulianoDepartment of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, ItalyThomas FilleronDepartment of Biostatistics, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, FranceChiara ZerbinatiDepartment of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, ItalyMaud VoisinDepartment of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, FranceCécile ArellanoInstitut Claudius RegaudÉtienne ChatelutInstitut Claudius-Regaud, IUCT-Oncopole and EA4553 University of Toulouse III Paul-Sabatier, Toulouse, FrancePierre MarquetUniversité de LimogesMohammad SamadiLCPMC-A2, ICPM, Département de Chimie, University of Lorraine, Metz, FranceHenri RochéDepartment of Medical Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse, FranceMarc PoirotInserm UMR 1037, Team “Cholesterol metabolism and therapeutic innovations”, Cancer Research Center of Toulouse, Toulouse, FranceSandrine Silvente‐PoirotInserm UMR 1037, Team "Cholesterol metabolism and therapeutic innovations", Cancer Research Center of Toulouse, Toulouse, France
2016en
Ochiq kirish: yoʻq
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba